SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-19-040982
Filing Date
2019-08-21
Accepted
2019-08-21 17:05:51
Documents
5
Period of Report
2019-09-27

Document Format Files

Seq Description Document Type Size
1 PRE 14A tv528107_pre14a.htm PRE 14A 269996
2 GRAPHIC tv528107_img1.jpg GRAPHIC 9415
3 GRAPHIC tv528107_img2.jpg GRAPHIC 9301
4 GRAPHIC tv528107_img3.jpg GRAPHIC 307093
5 GRAPHIC tv528107_img4.jpg GRAPHIC 163730
  Complete submission text file 0001144204-19-040982.txt   945884
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-15070 | Film No.: 191043635
SIC: 2834 Pharmaceutical Preparations